Optimind Pharma (XCNQ:OMND) EV-to-EBIT : -0.40 (As of May. 18, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Optimind Pharma's Enterprise Value is C$1.03 Mil. Optimind Pharma's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 was C$-2.58 Mil. Therefore, Optimind Pharma's EV-to-EBIT for today is -0.40.

The historical rank and industry rank for Optimind Pharma's EV-to-EBIT or its related term are showing as below:

XCNQ:OMND' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.34 Med: -0.83 Max: -0.38
Current: -0.4

During the past 2 years, the highest EV-to-EBIT of Optimind Pharma was -0.38. The lowest was -3.34. And the median was -0.83.

XCNQ:OMND's EV-to-EBIT is ranked worse than
100% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.96 vs XCNQ:OMND: -0.40

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Optimind Pharma's Enterprise Value for the quarter that ended in Nov. 2023 was C$1.52 Mil. Optimind Pharma's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 was C$-2.58 Mil. Optimind Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 was -169.48%.

Optimind Pharma EV-to-EBIT Historical Data

The historical data trend for Optimind Pharma's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma EV-to-EBIT Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

EV-to-EBIT

-1.32

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
EV-to-EBIT	Get a 7-Day Free Trial			-	-1.32	-0.85	-0.91	-0.59

Competitive Comparison of Optimind Pharma's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimind Pharma's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's EV-to-EBIT falls into.

Optimind Pharma EV-to-EBIT Calculation

Optimind Pharma's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	1.030	/	-2.576
	=	-0.40

Optimind Pharma's current Enterprise Value is C$1.03 Mil.
Optimind Pharma's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.58 Mil.

Optimind Pharma (XCNQ:OMND) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Optimind Pharma's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Nov. 2023 )	=	EBIT	/	Enterprise Value (Q: Nov. 2023 )
	=	-2.576	/	1.51992
	=	-169.48 %

Optimind Pharma's Enterprise Value for the quarter that ended in Nov. 2023 was C$1.52 Mil.
Optimind Pharma's EBIT for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.58 Mil.

Optimind Pharma EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines